title: Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
authors.forename: Aldo
authors.initials: A
authors.lastname: Marrone
authors.forename: Rosa
authors.initials: R
authors.lastname: Zampino
authors.forename: Marcello
authors.initials: M
authors.lastname: D'Onofrio
authors.forename: Raffaella
authors.initials: R
authors.lastname: Ricciotti
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ruggiero
authors.forename: Riccardo
authors.initials: R
authors.lastname: Utili
mesh_terms: D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D007372:Interferons